MyFinsight
Home
Blog
About
Cash and cash
equivalents
$26,686K
(817.04%↑ Y/Y)
Prepaid expense and
other current assets
$2,266K
(34.88%↑ Y/Y)
Accounts receivable, net
$206K
Ppe
$990K
Total current assets
$29,158K
(535.25%↑ Y/Y)
Goodwill (provisional)
$1,793K
Property and equipment,
net
$919K
Intangible assets, net
(provisional)
$832K
Right-of-use assets,
net-Nonrelated Party
$665K
Investments
$402K
Other assets
$224K
(-9.68%↓ Y/Y)
Right-of-use assets,
net-Related Party
$167K
Less accumulated
depreciation
$71K
Total assets
$34,160K
(606.08%↑ Y/Y)
Accumulated deficit
-$324,845K
(-7.79%↓ Y/Y)
Total liabilities and
stockholders' deficit
$34,160K
(606.08%↑ Y/Y)
Total stockholders
deficit
-$170K
(99.52%↑ Y/Y)
Additional paid-in capital
$324,632K
(22.17%↑ Y/Y)
Common stock, 0.001 par
value, 500,000,000...
$43K
(126.32%↑ Y/Y)
Total liabilities
$34,330K
(-15.14%↓ Y/Y)
Total current
liabilities
$33,874K
(-16.26%↓ Y/Y)
Lease liability,
noncurrent-Nonrelated Party
$396K
Lease liability,
noncurrent-Related Party
$60K
Warrant liabilities
$18,550K
(14.04%↑ Y/Y)
Accrued and other
current liabilities
$11,048K
(10.77%↑ Y/Y)
Accounts payable
$3,146K
(-13.33%↓ Y/Y)
Insurance loan payable
$412K
(8.99%↑ Y/Y)
Accrued clinical site
costs
$340K
(-3.13%↓ Y/Y)
Lease liability,
short...
$267K
Lease liability,
short term-Related...
$111K
Back
Back
Balance Sheet
NRX Pharmaceuticals, Inc. (NRXP)
NRX Pharmaceuticals, Inc. (NRXP)
source: myfinsight.com